High-Risk Clinical Trials in Shanghai, Shanghai Municipality
5 recruitingShanghai, Shanghai Municipality, China
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
Intermediate and High-risk Non-muscle Invasive Bladder Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.170 enrolled1 locationNCT06108492
Recruiting
Phase 3
Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer
High-risk Stage II Colorectal CancerStage III Colorectal CancerCirculating Tumor DNA Methylation
Fudan University340 enrolled1 locationNCT05954078
Recruiting
Phase 1Phase 2
The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma
High-Risk Localized Soft Tissue Sarcoma
Fudan University52 enrolled1 locationNCT05839275
Recruiting
Phase 1Phase 2
The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma
High-Risk Localized Soft Tissue Sarcoma
Fudan University52 enrolled1 locationNCT05774275
Recruiting
Phase 3
A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy
Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Jiangsu HengRui Medicine Co., Ltd.1,256 enrolled1 locationNCT05009290